Gender-Based Long-Term Outcomes After Revascularization for Three-Vessel Coronary Disease: A Propensity Score-Matched Analysis of a Large Cohort

References

• Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, et al; Group EUCCS. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37(1):24–34.
   PubMed Web of Science ®Google Scholar
• Khamis RY, Ammari T, Mikhail GW. Gender differences in coronary heart disease. Heart. 2016;102(14):1142–1149. doi:10.1136/heartjnl-2014-306463
   PubMed Web of Science ®Google Scholar
• Guo L, Lv H, Zhong L, et al. Gender differences in long-term outcomes of medical therapy and successful percutaneous coronary intervention for coronary chronic total occlusions. J Interv Cardiol. 2019;24:484–488.
   Google Scholar
• Hara H, Takahashi K, van Klaveren D, et al. Sex differences in all-cause mortality in the decade following complex coronary revascularization. J Am Coll Cardiol. 2020;76(8):889–899. doi:10.1016/j.jacc.2020.06.066
   PubMed Web of Science ®Google Scholar
• Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174(10):1630–1639. doi:10.1001/jamainternmed.2014.3904
   PubMed Web of Science ®Google Scholar
• Min JK, Dunning A, Lin FY, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT angiography evaluation for clinical outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58(8):849–860. doi:10.1016/j.jacc.2011.02.074
   PubMed Web of Science ®Google Scholar
• Xu JJ, Zhang Y, Jiang L, et al. Comparison of long-term outcomes in patients with premature triple-vessel coronary disease undergoing three different treatment strategies: a Prospective Cohort Study. Chin Med J. 2018;131(1):1–9. doi:10.4103/0366-6999.221273
   PubMed Web of Science ®Google Scholar
• Thuijs DJFM, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325–1334. doi:10.1016/S0140-6736(19)31997-X
   PubMed Web of Science ®Google Scholar
• Guo L, Wang J, Ding H, et al. Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol. 2020;19(1):100. doi:10.1186/s12933-020-01087-4
   PubMed Web of Science ®Google Scholar
• Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122(10):949–957. doi:10.1161/CIRCULATIONAHA.109.911669
   PubMed Web of Science ®Google Scholar
• Hollenbeak CS, Weisman CS, Rossi M, Ettinger SM. Gender disparities in percutaneous coronary interventions for acute myocardial infarction in Pennsylvania. Med Care. 2006;44(1):24–30. doi:10.1097/01.mlr.0000188915.66942.69
   PubMed Web of Science ®Google Scholar
• Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334(20):1311–1315. doi:10.1056/NEJM199605163342007
   PubMed Web of Science ®Google Scholar
• Guo L, Lv HC, Huang RC. Percutaneous coronary intervention in elderly patients with coronary chronic total occlusions: current evidence and future perspectives. Clin Interv Aging. 2020;15:771–781. doi:10.2147/CIA.S252318
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54(17):1561–1575. doi:10.1016/j.jacc.2009.04.098
   PubMed Web of Science ®Google Scholar
• Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133(9):916–947. doi:10.1161/CIR.0000000000000351
   PubMed Web of Science ®Google Scholar
• Heer T, Hochadel M, Schmidt K, et al. Sex differences in percutaneous coronary intervention-insights from the coronary angiography and PCI registry of the German Society of Cardiology. J Am Heart Assoc. 2017;6(3):e004972. doi:10.1161/JAHA.116.004972
   PubMed Web of Science ®Google Scholar
• Kovacic JC, Mehran R, Karajgikar R, et al. Female gender and mortality after percutaneous coronary intervention: results from a large registry. Catheter Cardiovasc Interv. 2012;80(4):514–521. doi:10.1002/ccd.23338
   PubMed Web of Science ®Google Scholar
• Duvernoy CS, Smith DE, Manohar P, et al. Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. Am Heart J. 2010;159(4):677–683.e671. doi:10.1016/j.ahj.2009.12.040
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005;111(7):940–953. doi:10.1161/01.CIR.0000155337.50423.C9
   PubMed Web of Science ®Google Scholar
• Thompson CA, Kaplan AV, Friedman BJ, et al. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheter Cardiovasc Interv. 2006;67(1):25–31. doi:10.1002/ccd.20564
   PubMed Web of Science ®Google Scholar
• Fath-Ordoubadi F, Barac Y, Abergel E, et al. Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents. Am J Cardiol. 2012;110(5):636–642. doi:10.1016/j.amjcard.2012.04.039
   PubMed Web of Science ®Google Scholar
• Guo L, Zhong L, Chen K, Wu J, Huang RC. Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions. Hellenic J Cardiol. 2018;59:281–287. doi:10.1016/j.hjc.2018.03.005
   PubMed Web of Science ®Google Scholar
• Bertaina M, De Filippo O, Iannaccone M, et al. Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials. J Cardiovasc Med. 2018;19(10):554–563. doi:10.2459/JCM.0000000000000703
   Google Scholar
• Yang L, Guo L, Lv H, et al. Predictors of adverse events among chronic total occlusion patients undergoing successful percutaneous coronary intervention and medical therapy. Clin Interv Aging. 2021;16:1847–1855. doi:10.2147/CIA.S337069
   PubMed Web of Science ®Google Scholar
• Bruno F, D’Ascenzo F, Marengo G, et al. Fractional flow reserve guided versus angiographic guided surgical revascularization: a meta-analysis. Catheter Cardiovasc Interv. 2021;98(1):E18–E23. doi:10.1002/ccd.29427
   PubMed Web of Science ®Google Scholar